These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19818754)

  • 1. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
    Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
    Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation.
    Little PJ; Getachew R; Rezaei HB; Sanchez-Guerrero E; Khachigian LM; Wang H; Liao S; Zheng W; Ballinger ML; Osman N
    Arch Biochem Biophys; 2012 Sep; 525(1):25-31. PubMed ID: 22683649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
    Ivey ME; Little PJ
    Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation.
    Osman N; Getachew R; Thach L; Wang H; Su X; Zheng W; Little PJ
    Cell Signal; 2014 May; 26(5):912-6. PubMed ID: 24462709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
    Schönherr E; Kinsella MG; Wight TN
    Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.
    Getachew R; Ballinger ML; Burch ML; Reid JJ; Khachigian LM; Wight TN; Little PJ; Osman N
    Endocrinology; 2010 Sep; 151(9):4356-67. PubMed ID: 20610572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
    Liu Y; Dolence J; Ren J; Rao M; Sreejayan N
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation.
    Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
    Ballinger ML; Osman N; Wilks AF; Su S; Burns CJ; Bu X; Little PJ
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
    Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
    Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
    Kamato D; Babaahmadi Rezaei H; Getachew R; Thach L; Guidone D; Osman N; Roufogalis B; Duke CC; Tran VH; Zheng W; Little PJ
    J Pharm Pharmacol; 2013 Jul; 65(7):1026-36. PubMed ID: 23738730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endothelial-cell-conditioned medium on proteoglycan synthesis in cultured smooth muscle cells from pig aorta.
    Berrou E; Breton M; Deudon E; Picard J
    J Cell Physiol; 1988 Dec; 137(3):430-8. PubMed ID: 3142885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
    Little PJ; Rostam MA; Piva TJ; Getachew R; Kamato D; Guidone D; Ballinger ML; Zheng W; Osman N
    J Pharm Pharmacol; 2013 Jul; 65(7):1055-63. PubMed ID: 23738733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation.
    Yang SN; Burch ML; Getachew R; Ballinger ML; Osman N; Little PJ
    Arch Physiol Biochem; 2009 Jul; 115(3):147-54. PubMed ID: 19580379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β stimulates biglycan core protein synthesis but not glycosaminoglycan chain elongation via Akt phosphorylation in vascular smooth muscle.
    Osman N; Getachew R; Burch M; Lancaster G; Wang R; Wang H; Zheng W; Little PJ
    Growth Factors; 2011 Oct; 29(5):203-10. PubMed ID: 21913799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.